CORAL SPRINGS, Fla.--(BUSINESS WIRE)--Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that they have completed the process of moving their inventory of their all-natural, non-addictive pain reliever, Nyloxin®, into their Plantation, Florida facility and that they will be handling fulfillment services in-house.
Help employers find you! Check out all the jobs and post your resume.